Akebia Therapeutics (AKBA)
(Delayed Data from NSDQ)
$1.15 USD
+0.01 (0.88%)
Updated May 17, 2024 04:00 PM ET
After-Market: $1.16 +0.01 (0.87%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/23/2024
Time: -- |
6/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, Akebia Therapeutics (AKBA) reported earnings of -$0.09 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for AKBA's next earnings release expected on August 23, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year decrease of 16.67%.
Earnings History
Price & Consensus
Zacks News for AKBA
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD
AKBA: What are Zacks experts saying now?
Zacks Private Portfolio Services